Abstract
After more than 60 years of investigations into the use of allogeneic haematopoietic cell transplantation for treatment of otherwise fatal malignant and non-malignant blood disorders, this procedure has been transformed from one that was thought to be plagued with insurmountable difficulties to a standard therapy for many haematological diseases. How have these problems been overcome and how was this procedure extended to include patients who were too old or medically unfit to tolerate conventional, high-intensity transplant approaches?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have